MusclePharm Corporation Stock Other OTC

Stocks

18/10/23	Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	CI
10/10/23	FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).	CI
03/10/23	Motion for Asset Sale Approved for MusclePharm Corporation	CI
27/09/23	FitLife Brands, Inc. entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.	CI
08/09/23	Stalking Horse Agreement Filed by MusclePharm Corporation	CI
01/09/23	Musclepharm Corporation Announces Resignation of Paul Karr as Director	CI
28/08/23	Second Amended Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	CI
28/08/23	First Amended Disclosure Statement Approved for MusclePharm Corporation	CI
17/08/23	Bidding Procedure Approved for MusclePharm Corporation	CI
20/07/23	Musclepharm Corporation Terminates Gary Shirshac as Chief Financial Officer	CI
19/06/23	First Amended Reorganization Plan and DIsclosure Statement Filed by MusclePharm Corporation	CI
26/05/23	Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	CI
12/05/23	Motion for Asset Sale Filed by MusclePharm Corporation	CI

28/06/23	SEC Charges Former MusclePharm Executives with Accounting and Disclosure Fraud	AQ
30/09/22	MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	AQ
19/09/22	MusclePharm : Accelaration/Increase of Financial Obligation - Form 8-K	PU
19/09/22	MUSCLEPHARM CORP : Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement (form 8-K)	AQ
24/08/22	MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	AQ

1 day

+12.00%

Manager	Title	Age	Since
Tyler Jeffrey Dillashaw PRN	Corporate Officer/Principal	-	01/10/2021
Jason Keenan PRN	Corporate Officer/Principal	-	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MUSCLEPHARM CORPORATION	+12.00%	+86.67%	-	-	33
CHURCHILL CAPITAL CORP XI	-3.83%	-8.06%	-	-	686M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	-0.07%	-0.07%	-	-	647M
BAIN CAPITAL GSS INVESTMENT CORP.	-0.10%	-0.24%	-	-	601M
CHURCHILL CAPITAL CORP XII	+0.46%	+0.65%	-	-	599M
CANTOR EQUITY PARTNERS IV, INC.	0.00%	-0.43%	+1.87%	-	592M
CENTIEL AG	+1.75%	+3.93%	+257.49%	-78.60%	582M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	-0.70%	-0.96%	-	-	559M
CHURCHILL CAPITAL CORP XIII	+0.76%	+0.66%	-	-	513M
Average	+1.14%	-0.57%	+129.68%	-78.60%	597.34M
Weighted average by Cap.	-0.30%	-0.73%	+128.63%	-78.60%